Search Results - "NOS, C"

Refine Results
  1. 1

    Complications of lymphadenectomy for gynecologic cancer by Achouri, A, Huchon, C, Bats, A.S, Bensaid, C, Nos, C, Lécuru, F

    Published in European journal of surgical oncology (01-01-2013)
    “…Abstract Introduction Symptomatic postoperative lymphocysts (SPOLs) and lower-limb lymphedema (LLL) are probably underestimated complications of…”
    Get full text
    Journal Article
  2. 2

    Oncoplastic surgery for breast cancer based on tumour location and a quadrant-per-quadrant atlas by Clough, K. B., Ihrai, T., Oden, S., Kaufman, G., Massey, E., Nos, C.

    Published in British journal of surgery (01-10-2012)
    “…Background: The majority of published techniques for oncoplastic surgery rely on an inverted‐$\hbox{T}$ mammoplasty, independent of tumour location. These…”
    Get full text
    Journal Article
  3. 3

    Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? by TINTORE, M, ROVIRA, A, MONTALBAN, X, RIO, J, TUR, C, PELAYO, R, NOS, C, TELLEZ, N, PERKAL, H, COMABELLA, M, SASTRE-GARRIGA, J

    Published in Neurology (25-03-2008)
    “…To evaluate whether oligoclonal bands (OB) add information to MRI in predicting both a second attack and development of disability in patients with clinically…”
    Get full text
    Journal Article
  4. 4

    Baseline MRI predicts future attacks and disability in clinically isolated syndromes by TINTORE, M, ROVIRA, A, RIO, J, NOS, C, GRIVE, E, TELLEZ, N, PELAYO, R, COMABELLA, M, SASTRE-GARRIGA, J, MONTALBAN, X

    Published in Neurology (26-09-2006)
    “…To determine the relation between baseline MRI and both conversion to multiple sclerosis (MS) and development of disability in a cohort of patients with…”
    Get full text
    Journal Article
  5. 5

    A prospective randomized study comparing centrifugation and sedimentation for fat grafting in breast reconstruction by Sarfati, I., M.D, van la Parra, R.F.D., M.D., PhD, Terem-Rapoport, C.A., M.D, Benyahi, D., M.D, Nos, C., M.D, Clough, K.B., M.D

    “…Abstract Background Fat grafting is an efficient method to correct large volumetric defects after mastectomy.There is ongoing debate regarding the best method…”
    Get full text
    Journal Article
  6. 6

    Brainstem lesions in clinically isolated syndromes by TINTORE, M, ROVIRA, A, PEREZ-MIRALLES, F, HUERGA, E, COMABELLA, M, SASTRE-GARRIGA, J, MONTALBAN, X, ARRAMBIDE, G, MITJANA, R, RIO, J, AUGER, C, NOS, C, EDO, M. C, CASTILLO, J, HORGA, A

    Published in Neurology (23-11-2010)
    “…Number of baseline lesions has been shown to predict future attacks and disability in clinically isolated syndromes (CIS). To investigate the role of baseline…”
    Get full text
    Journal Article
  7. 7

    Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response by Río, J., Tintoré, M., Sastre-Garriga, J., Nos, C., Castilló, J., Tur, C., Comabella, M., Montalban, X.

    Published in European journal of neurology (01-06-2012)
    “…Background:  Therapy for multiple sclerosis (MS) has a partial efficacy, and a significant proportion of treated patients will develop a suboptimal response…”
    Get full text
    Journal Article
  8. 8

    Measures in the first year of therapy predict the response to interferon β in MS by Río, J, Castilló, J, Rovira, A, Tintoré, M, Sastre-Garriga, J, Horga, A, Nos, C, Comabella, M, Aymerich, X, Montalbán, X

    Published in Multiple sclerosis (01-07-2009)
    “…Background and objective Several criteria for treatment response to interferon beta (IFNβ) have been proposed, although there is no consensus among different…”
    Get full text
    Journal Article Publication
  9. 9

    Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? by Téllez, N, Río, J, Tintoré, M, Nos, C, Galán, I, Montalban, X

    Published in Multiple sclerosis (01-04-2005)
    “…Background: As a symptom of multiple sclerosis (MS), fatigue is difficult to manage because of its unknown etiology, the lack of efficacy of the drugs tested…”
    Get full text
    Journal Article
  10. 10

    Oncoplastic Level 2 Mammoplasty for Large DCIS: 5-Year Results by van la Parra, R. F. D., Clough, K. B., Lejalle-Alaeddine, C., Poulet, B., Sarfati, I., Nos, C.

    Published in Annals of surgical oncology (01-08-2019)
    “…Background Oncoplastic surgery (OPS) allows wider resections with immediate breast reshaping by mammoplasty. This study reviews our experience with level 2…”
    Get full text
    Journal Article
  11. 11

    Clinical impact of early brain atrophy in clinically isolated syndromes by Pérez-Miralles, F, Sastre-Garriga, J, Tintoré, M, Arrambide, G, Nos, C, Perkal, H, Río, J, Edo, MC, Horga, A, Castilló, J, Auger, C, Huerga, E, Rovira, A, Montalban, X

    Published in Multiple sclerosis (01-12-2013)
    “…Background: The impact of global and tissue-specific brain atrophy on conversion to multiple sclerosis (MS) after a clinically isolated syndrome (CIS) is not…”
    Get full text
    Journal Article
  12. 12

    New anatomical classification of the axilla with implications for sentinel node biopsy by Clough, K. B., Nasr, R., Nos, C., Vieira, M., Inguenault, C., Poulet, B.

    Published in British journal of surgery (01-11-2010)
    “…Background: The exact anatomical location of the sentinel lymph node (SLN) in the axilla has not ascertained clinically, but could be useful both for teaching…”
    Get full text
    Journal Article
  13. 13

    Adipose-tissue grafting to the post-mastectomy irradiated chest wall: Preparing the ground for implant reconstruction by Sarfati, I, Ihrai, T, Kaufman, G, Nos, C, Clough, K.B

    “…Summary Introduction Breast implant reconstruction after radiotherapy carries a high risk of failure and complication. Nevertheless, it may be the only…”
    Get full text
    Journal Article
  14. 14

    A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS by Ramo-Tello, C, Grau-López, L, Tintoré, M, Rovira, A, Ramió i Torrenta, L, Brieva, L, Cano, A, Carmona, O, Saiz, A, Torres, F, Giner, P, Nos, C, Massuet, A, Montalbán, X, Martínez-Cáceres, E, Costa, J

    Published in Multiple sclerosis (01-05-2014)
    “…Background: Steroids improve multiple sclerosis (MS) relapses but therapeutic window and dose, frequency and administration route remain uncertain. Objective:…”
    Get full text
    Journal Article
  15. 15

    Significant clinical worsening after natalizumab withdrawal: Predictive factors by Vidal-Jordana, A, Tintoré, M, Tur, C, Pérez-Miralles, F, Auger, C, Río, J, Nos, C, Arrambide, G, Comabella, M, Galán, I, Castilló, J, Sastre-Garriga, J, Rovira, A, Montalban, X

    Published in Multiple sclerosis (01-05-2015)
    “…We aimed to single out multiple sclerosis (MS) cases with poor outcome after natalizumab withdrawal and to identify predictive variables. We ascertained 47…”
    Get full text
    Journal Article
  16. 16

    Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients by Río, J, Rovira, À, Tintoré, M, Huerga, E, Nos, C, Tellez, N, Tur, C, Comabella, M, Montalban, X

    Published in Multiple sclerosis (01-05-2008)
    “…Objective Our objective in this study is to evaluate whether brain magnetic resonance imaging (MRI) performed at interferon-beta (IFN-β) onset and after 12…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    New diagnostic criteria for multiple sclerosis: Application in first demyelinating episode by TINTORE, M, ROVIRA, A, RIO, J, NOS, C, GRIVE, E, SASTRE-GARRIGA, J, PERICOT, I, SANCHEZ, E, COMABELLA, M, MONTALBAN, X

    Published in Neurology (14-01-2003)
    “…Recently developed diagnostic criteria for MS (McDonald criteria) indicate that in patients with a single demyelinating episode (clinically isolated syndromes…”
    Get full text
    Journal Article
  20. 20